Hidradenitis Suppurativa
The medical term for recurrent hemopurulent (blood and pus-filled) abscesses or pustules is hidradenitis suppurativa (HS), also known as acne inversa.
Definition and Clinical Presentation
Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent nodules and abscesses that rupture and lead to sinus tracts (tunnels) and scarring 1. The condition primarily affects intertriginous areas—the axillae, inguinal and anogenital regions, and inframammary areas 1.
The key distinguishing features include:
- Recurrent painful nodules that progress to abscesses
- Hemopurulent drainage (mixture of blood and pus)
- Tunnel formation (previously called sinus tracts or fistulas)
- Scarring with chronic inflammation
- Location: body folds and areas with apocrine glands
Important Distinction from Other Conditions
Do not confuse HS with simple recurrent abscesses or furunculosis. While recurrent abscesses at the same site may be caused by local factors such as foreign material, pilonidal cysts, or simple furunculosis 2, HS is a distinct chronic inflammatory disease with a different pathophysiology and treatment approach.
Key Differentiating Features:
Furunculosis (recurrent boils):
- Hair follicle infections caused by S. aureus 3
- Individual lesions that drain and heal
- Typically respond to incision/drainage and decolonization strategies
- Do not form tunnels or extensive scarring
Hidradenitis Suppurativa:
- Chronic inflammatory disease of the hair follicle unit 1
- Progressive with tunnel formation and architectural tissue changes
- Requires systemic anti-inflammatory therapy
- Associated with significant comorbidities (metabolic syndrome, inflammatory bowel disease, depression) 4, 5
Diagnostic Approach
The diagnosis is clinical—there are no pathognomonic laboratory tests 4. Look for:
- Typical lesion morphology: painful nodules, abscesses, draining tunnels
- Characteristic locations: axillae, groin, perianal, inframammary areas
- Recurrent pattern: at least 2 occurrences in 6 months
- Chronicity: lesions that persist or recur over time
Ultrasound imaging is emerging as a useful tool for assessing deep-seated lesions and tunnels that may not be apparent on surface examination 4.
Clinical Pitfalls
- Diagnostic delay is common—patients often wait years before correct diagnosis 4
- Do not label HS lesions as "cellulitis"—the primary treatment for HS is not antibiotics alone but requires anti-inflammatory therapy and often surgical intervention 2
- Recurrent abscesses in the same location should prompt evaluation for HS, especially in intertriginous areas 2
- Screen for comorbidities: metabolic syndrome, inflammatory bowel disease, depression, and polycystic ovarian syndrome are strongly associated 4, 5
Management Framework
Diagnosis should be made by a dermatologist or healthcare professional with expert knowledge in HS 1. Treatment is multimodal and depends on severity:
Mild Disease (Hurley Stage I):
- Topical clindamycin 1% solution/gel twice daily for 12 weeks, OR
- Tetracycline 500 mg orally twice daily for 4 months 1
Moderate-to-Severe Disease:
- Clindamycin 300 mg orally twice daily with rifampin 600 mg orally once daily for 10 weeks 1
- If inadequate response: Adalimumab (160 mg at week 0,80 mg at week 2, then 40 mg subcutaneously weekly) 1
Adjunctive Measures (All Patients):
- Pain management
- Weight loss counseling
- Tobacco cessation
- Treatment of superinfections
- Appropriate wound dressings 1
Surgical intervention should be assessed in all patients depending on the extent of scarring and tunnel formation 1, 6.
Critical Point
The distinction between HS and simple recurrent abscesses is clinically crucial because the primary treatment differs fundamentally: simple abscesses require drainage with possible decolonization strategies 2, while HS requires chronic anti-inflammatory medical therapy, often combined with surgical intervention, to prevent progressive tissue destruction 1, 6, 5.